Vol.74 No.5 September 2026

Incidence of puerperal fever following discontinuation of prophylactic antimicrobials after vaginal delivery: an observational survey

Yugo Fukamizu, Rie Sakamoto, Makoto Higashi, Ken Sakai, Norihiro Koyama and Junichi Hanaka

Jpn. J. Chemother. 74 (5): 531-537, 2026

Is early oral switch after short-term intravenous therapy feasible in antimicrobial treatment of native vertebral osteomyelitis?— A retrospective analysis of 65 patients —

Taku Ozawa, Mutsunobu Yoshioka, Satoshi Ishizu and Osamu Yohena

Jpn. J. Chemother. 74 (5): 538-546, 2026

Impact of daily antimicrobial stewardship team activities in a hospital without infectious disease physicians or dedicated AST pharmacists: A retrospective study of blood culture–positive patients

Shinji Sawada, Masaki Fujita, Sho Kishimoto, Yohei Mitsutaka, Koki Yoshimura, Sho Oyama, Takahiro Hyuga, Atsuhiro Morita and Kanji Tomogane

Jpn. J. Chemother. 74 (5): 547-555, 2026

A case of hyperammonemia associated with Corynebacterium urealyticum urinary tract infection and urinary dysfunction

Ichie Akahoshi and Yasutaka Tohyama

Jpn. J. Chemother. 74 (5): 556-562, 2026

A case of severe fever with thrombocytopenia syndrome in an elderly patient in whom a favorable outcome was achieved despite initiation of favipiravir only on day 6 after symptom onset: importance of assessing treatment indication based on the clinical condition at the time of initiation

Yasuhiro Ue, Atsuyoshi Okada, Takeshi Nakamura, Kazuya Ishii, Nobutoshi Otsuka and Taro Masunari

Jpn. J. Chemother. 74 (5): 563-568, 2026